Enjoy complimentary customisation on priority with our Enterprise License!
The solubility enhancement excipients for osdf market size is forecast to increase by USD 6.37 billion, at a CAGR of 16.25% between 2023 and 2028.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The solubility enhancement excipients market continues to evolve, driven by the persistent demand for improving the bioavailability of poorly soluble drugs. Pre-formulation studies play a crucial role in this process, providing insights into the fundamental properties of active pharmaceutical ingredients (APIs) and guiding the selection of appropriate formulation development strategies. Several approaches have emerged to enhance solubility, including solid dispersion systems, co-solvency, and nanotechnology-based methods like nanonization. Solid dispersion systems, for instance, have shown remarkable success in increasing the solubility and bioavailability of various APIs. For instance, a study reported a 20-fold increase in the dissolution rate of a poorly soluble drug using a solid dispersion formulation.
Pharmaceutical development teams employ various solubility enhancement techniques, such as particle size reduction, lipid-based formulations, and cyclodextrin inclusion complexes, to optimize formulation composition and improve oral absorption kinetics. Excipient selection is a critical aspect of formulation development, with considerations given to factors like excipient compatibility, dissolution mechanism, and surfactant characterization. Process analytical technology (PAT) and in-vitro dissolution testing are essential tools in the development and optimization of solubility enhancement formulations. These techniques enable real-time monitoring of formulation composition and performance, ensuring consistent quality and efficacy. Industry growth in the solubility enhancement excipients market is expected to remain robust, with estimates suggesting a steady expansion of over 5% annually.
The continuous unfolding of market activities and evolving patterns underscore the importance of staying abreast of the latest trends and advancements in this field.
The solubility enhancement excipients for osdf industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The solid dispersion segment is estimated to witness significant growth during the forecast period.
In the realm of pharmaceutical development, the challenge of enhancing the solubility and bioavailability of poorly water-soluble drugs continues to be a significant focus. Solid dispersion systems, a technology that disperses active ingredients in an inert matrix, have emerged as a popular solution. This approach improves drug dissolution rates, thereby increasing oral bioavailability. Pre-formulation studies are essential in this process, guiding the selection of appropriate excipients and solubility enhancement techniques such as co-solvency and nanoparticle formation. Pharmaceutical companies invest heavily in formulation development, employing techniques like particle size reduction, lipid-based formulations, and solubility enhancement methods. Crystal engineering and cyclodextrin inclusion complexes are among the strategies used to optimize drug dissolution.
In vitro dissolution testing is a crucial step in evaluating the effectiveness of these approaches. Process analytical technology plays a pivotal role in monitoring and controlling the manufacturing process, ensuring consistent drug quality. Scale-up manufacturing requires careful consideration of excipient compatibility, wetting agents selection, and stability testing protocols. Micronization technology and physicochemical characterization are essential in understanding the impact of formulation composition on drug behavior. The pharmaceutical industry anticipates continued growth, with market size projected to expand by 15% annually. For instance, a recent study revealed that a solid dispersion formulation of a poorly soluble drug achieved a 30% increase in dissolution rate compared to the conventional tablet formulation.
This success underscores the importance of solubility enhancement in drug manufacturing.
The Solid dispersion segment was valued at USD 1.02 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 37% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The solubility enhancement excipients market for Oral Solid Dosage Forms (OSDF) in North America is projected to expand significantly during the forecast period. The region's growth can be attributed to its advanced healthcare infrastructure and a robust pharmaceutical industry, particularly in the US. Major pharmaceutical companies, including Pfizer Inc., Johnson and Johnson, Roche Holding AG, and AbbVie Inc., are headquartered in the US and contribute significantly to the market. These companies focus on technological advancements and product launches to strengthen their portfolios and maintain a competitive edge. Formulation development is a crucial aspect of the pharmaceutical industry, and solubility enhancement excipients play a vital role in improving drug bioavailability.
Pre-formulation studies and particle size reduction techniques, such as micronization technology, are employed to enhance the solubility of drugs. Solid dispersion systems, co-solvency approaches, and lipid-based formulations are popular solubility enhancement techniques. Process analytical technology (PAT) and in-vitro dissolution testing are essential tools for evaluating the effectiveness of solubility enhancement excipients. Crystal engineering methods, such as nanonization techniques, are used to modify the crystal structure of drugs to enhance their solubility. Cyclodextrin inclusion complexes are a common form of solubility enhancement, where cyclodextrins encapsulate drugs to improve their solubility. Excipient selection, compatibility studies, and stability testing protocols are crucial aspects of formulation development.
Surfactants, wetting agents, polymers, and other excipients are carefully selected based on their ability to improve drug dissolution rates and oral absorption kinetics. Polymer selection criteria include factors such as solubility, stability, and compatibility with the drug. The North American solubility enhancement excipients market for OSDF is expected to experience substantial growth due to the region's advanced healthcare infrastructure and robust pharmaceutical industry. Companies are focusing on technological advancements, product launches, and formulation development to improve drug bioavailability and enhance their businesses.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global market for solubility enhancement excipients in the OSDF (oral solid dosage forms) sector is experiencing significant growth due to the increasing demand for improving drug bioavailability and addressing the challenge of poor water solubility in many active pharmaceutical ingredients (APIs). Cyclodextrins, a common type of solubility enhancement excipient, play a crucial role in this regard by forming inclusion complexes with APIs, thereby enhancing their solubility and dissolution rates. The particle size of drugs significantly impacts their dissolution behavior, making particle size reduction an essential aspect of formulation development. Solid dispersion formulation strategies are employed to enhance the wettability and dissolution rate of drugs by converting them into amorphous solid solutions.
Excipient selection for enhanced bioavailability is another critical factor, with the compatibility of excipients and drugs being a key consideration to ensure drug stability. Designing stable oral solid dosage forms involves optimizing formulation composition, excipient selection, and manufacturing processes. Controlled release oral formulations are a popular application of solubility enhancement excipients, requiring precise formulation design and evaluation using USP apparatus. Optimization of lipid-based drug delivery systems and characterization of solid dispersions using techniques such as DSC (differential scanning calorimetry) are essential for ensuring the desired physicochemical properties. Surfactants are often used to enhance wetting and solubility, and their selection plays a significant role in the success of OSDF development.
Regulatory guidelines for oral solid dosage forms provide a framework for ensuring quality and safety, with stringent requirements for excipient selection, manufacturing processes, and stability testing. Scale-up and manufacturing of solid dispersions require robust and scalable processes, with quality control methods for pharmaceutical excipients being essential to maintain consistency and ensure product purity. Stability testing protocols for oral solid dosage forms are critical to assessing the long-term stability of formulations and ensuring they meet regulatory requirements. In vitro dissolution testing methods for OSDF, such as measuring drug dissolution rate using UV-vis spectroscopy, provide valuable information on formulation performance and bioavailability. Understanding the impact of polymorphism on drug bioavailability is also crucial for optimizing formulation design and ensuring consistent product performance.
The solubility enhancement excipients for osdf market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the solubility enhancement excipients for osdf market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, solubility enhancement excipients for osdf market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abitec - The company specializes in providing Acconon excipients, which enhance the solubility of poorly water-soluble drugs through direct solubilization, thereby improving their bioavailability. These excipients are essential for pharmaceutical formulations, enabling better absorption and efficacy of medications.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Solubility Enhancement Excipients for OSDF Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
185 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 16.25% |
|
Market growth 2024-2028 |
USD 6373.58 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
15.72 |
|
Key countries |
US, Canada, China, Germany, and Italy |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this solubility enhancement excipients for osdf market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Technology
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
